Search

everythinglearnresearchcommunity

for

Search:↓

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

FPHL causes hair loss in women due to genetics and hormones; minoxidil and anti-androgens are treatments, and early intervention is advised.

RhoA helps skin stem cells grow, aiding wound healing.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Men with more vanadium in their blood and who drink less soy milk are more likely to have hair loss.

Combination therapy with oral contraceptives and spironolactone improves hair growth, menstrual issues, and acne in women with PCOS.

Vitamin D and estrogen may help protect heart and kidney health, and maintaining sufficient vitamin D levels could be especially beneficial for African Americans, postmenopausal women, and people with chronic kidney disease.

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

ERβ has potential in treating prostate cancer and neurodegenerative diseases, but human studies are needed before clinical use.

PRP may improve fertility treatment success but needs more research for safe use.

Lower zinc levels may predict less effective hair loss treatment.

Pretreatment methods can enhance bioactive content in lactogenic herbs.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

Small hormonal imbalances can cause significant health problems, so more sensitive testing for hormone-disrupting chemicals is needed.

Placental extracts have antioxidant, anti-inflammatory, and immune-boosting effects, but their exact workings are unclear.

Review finds no permanent solution for female hair loss.

Review determines effective, safe treatments for female hair loss.

Hair loss caused by longer latent hair cycle and sudden miniaturization, not gradual follicle size reduction.

The document concludes that management strategies for PCOS are important due to its common occurrence and associated health risks.

Glypican-4 may help indicate insulin sensitivity and lipid issues in women with PCOS.

Blocking both main energy pathways can stop hair follicle stem cell-induced skin cancer growth.

Encapsulating hair loss drugs in cyclodextrins improves their solubility and reduces scalp irritation.

DHEA improved brain function and behavior in old monkeys and had additional health benefits.

Excessive hair growth in women, often from high androgen levels, is usually caused by PCOS, and can be treated with hair removal, medication, and possibly weight loss.

Hair loss caused by longer latent hair cycle and sudden miniaturization, not gradual follicle size reduction.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

Vaccination is crucial for public health, but anti-vaccine movements are a concern.